Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability

Abstract

Lipophilic compounds constitute a majority of therapeutics in the pipeline of drug discovery. Despite possessing enhanced efficacy and permeability, some of these drugs suffer poor solubility necessitating the need of a suitable drug delivery system. Nanoemulsion is a drug delivery system that provides enhanced solubility for poorly soluble drugs in an attempt to improve the oral bioavailability. The purpose of this study is to develop a nanoemulsion system using ibuprofen as a model drug in order to investigate the potential of this colloidal system to enhance the absorption of poorly water-soluble drugs. Ibuprofen loaded-nanoemulsion with different drug concentrations (1.5, 3 and 6% w/w) were formulated from olive oil, sucrose ester L-1695 and glycerol using D-phase emulsification technique. A pseudoternary phase diagram was utilised to identify the optimal excipient composition to formulate the nanoemulsion system. In vitro diffusion chamber studies using rodent intestinal linings highlighted improved absorption profile when ibuprofen was delivered as nanoemulsion in comparison to microemulsions and drug-in-oil systems. This was further corroborated by in vivo studies using rat model that highlighted a two-fold increase in ibuprofen absorption when the drug was administered as a nanoemulsion relative to drug-in-oil system. On the other hand, when ibuprofen was administered as microemulsions, only a 1.5-fold increase in absorption was observed relative to drug-in-oil system. Thus, this study highlights the potential of using nanoemulsion as a drug delivery system to enhance the oral bioavailability of hydrophobic drugs.

Nanoemulsion and Solid Nanoemulsion for Improving Oral Delivery of a Breast Cancer Drug: Formulation, Evaluation, and a Comparison Study

“…FE-SEM is a microscopic test that can approve the particle size of the optimum formulation ( Anuar et al, 2020 ), which is NE-3. As clear from Fig.…”

A Customized Screening Tool Approach for the Development of a Self-Nanoemulsifying Drug Delivery System (SNEDDS)

“…Compared with the cited studies on SNEDDS development for the active ingredients celecoxib and fenofibrate, the approach using a special triangular mixture design provided formulations that might exhibit a better in vivo performance. Administering SNEDDS that provide much smaller droplet sizes after dispersion may lead to better drug absorption associated with increased bioavailability ( 14 , 38 ). A smaller droplet size also provided an indication of better physical stability ( 15 ) over the time as revealed by the emulsification performance tests.…”

“…Dissolving the drug in a water-free preconcentrate and obtaining a stable nanoemulsion after dispersion in an aqueous medium avoids the dissolution step of the solid prior to drug absorption and thus can facilitate drug absorption in the intestine. Particularly for highly permeable drug compounds, this can present with a higher bioavailability, which in this case is also often accompanied by more reliable in vivo plasma levels ( 14 , 15 ).…”

Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain

“…Nanoemulsions (NEs) are thermodynamically stable dispersions of oil and water that are stabilized by an interfacial film of surface active agents (Nanthakumar et al., 2016 ; Stoyanova et al., 2016 ; Anuar et al., 2020 ). They usually are prepared in a droplet size ranging from 100 to 1000 nm.…”